Shashank Upadhye’s Treatise on “Generic Pharmaceutical Patent & FDA Law” in its Sixth Edition

The 6th Edition (2013 Ed.) of "Generic Pharmaceutical Patent & FDA Law," the legal treatise written by Intellectual Property partner Shashank Upadhye, was published this month by Thomson Reuters (West).

This practitioner's guide walks the practitioner through the stages of drug approval, identifying the critical issues in the process and advising the client about the issues and areas of concern or exploitation. It discusses the areas that impact the interaction of patents and Food and Drug Administration law, including litigation.

Click here for more information.